Enhancer activity and eRNA transcription were analyzed to determine the region involved in MYC expression, and it was found that both the deletion of the MYC enhancers and the ASO-mediated inhibition of the corresponding eRNAs suppressed the proliferation and reduced spheroid formation in HCC cell lines. The gene discussed is MYC; the disease is hepatocellular carcinoma.